Third Quarter 2025 Q3 2025 Earnings Call Jon Carpenter Chief Executive Officer Mary Margaret Curry Chief Financial Officer Cautionary Note Regarding Forward-Looking Statements Third Quarter Highlights $88.9M Revenue +$0.4M year-over-year $11.0M Adj. EBITDA 12.4% margin rate This presentation contains forward-looking statements within the meaning of federal and state securities laws, including, without limitation, our expectations, forecasts, plans and opinions regarding expected revenue and adjusted EBITDA ...

业绩总结 - 2025年第三季度收入为8200万美元，同比增长34%[10] - 2025年第三季度毛利润为6500万美元，毛利率为79%[10] - 2025年第三季度调整后EBITDA为400万美元，调整后EBITDA率为5%[10] - 2025年第三季度末现金及现金等价物为5600万美元，债务为1900万美元[10] - 公司2024财年第一季度总收入为6450万美元，同比增长3.7%[85] - 公司2024财年第一季度总毛利为5170万美元，毛利率为80.1%[85] - 公司2024财年第一季度非GAAP调整后EBITDA为190万美元，EBITDA利润率为2.9%[86] - 公司2024财年第一季度总现金及等价物为6790万美元[85] 用户数据 - 2025年第三季度活跃买家数量为160万，同比增长26%[10] - 2025年第三季度订单数量为160万，同比增长37%[10] - 2024财年第一季度TTM活跃买家数量为129.6万，同比增长-2.5%[85] - 2024财年第一季度订单总数为118.2万，同比增长7.4%[85] 市场展望 - 预计2024-2029年美国二手服装市场年均增长率为9%[44] - 2024年美国二手服装市场增长14%，是整体零售服装市场的5倍[46] 新产品与技术 - 2024年通过RaaS项目列出230万件商品[55] - 2024年买家节省的金额达到76亿美元，相当于估计零售价格的90%[55] 费用与损失 - 2023年12月31日的持续经营损失为84,720万美元，2024年3月31日的持续经营损失为121,900万美元[89] - 2023年12月31日的调整后EBITDA为25,420万美元，2024年3月31日的调整后EBITDA为18,880万美元，调整后EBITDA利润率分别为4.1%和2.2%[89] - 2023年12月31日的股票补偿费用为65,070万美元，2024年3月31日的股票补偿费用为69,110万美元[89] - 2023年12月31日的折旧和摊销费用为36,650万美元，2024年3月31日的折旧和摊销费用为37,480万美元[89] - 2023年12月31日的利息费用为7,090万美元，2024年3月31日的利息费用为6,770万美元[89] - 2023年12月31日的裁员及其他重组费用为138万美元，2024年3月31日的裁员及其他重组费用为2,731万美元[89] - 2023年12月31日的销售、一般和行政费用为42,460万美元，2024年3月31日的销售、一般和行政费用为36,630万美元[89] - 2024财年第一季度总运营费用为6410万美元，同比仅增长1.3%[86] - 2024财年第一季度市场营销费用同比下降18.9%[86] - 2024财年第一季度销售、一般和行政费用占收入的25.0%[86] - 2024财年第一季度运营、产品和技术费用占收入的57.5%[86]

3Q 2025 Earnings Conference Call November 4, 2025 Forward-Looking Statements Statements made during this presentation that set forth expectations, predictions, projections or are about future events are based on facts and situations that are known to us as of November 4, 2025. We believe that our expectations and assumptions are reasonable. Actual results may differ materially, due to risks and uncertainties, such as those described on pages 24-35 of our Form 10-Q filed on May 6, 2025 and other subsequent f ...

Investor Presentation November 2025 Safe Harbor Forward-Looking Statements - This presentation and accompanying oral presentation contain "forward-looking statements" regarding our future performance, including but not limited to estimates regarding revenue, non-GAAP gross margin, and non-GAAP operating margin for the fourth quarter and fiscal year 2025 and 2026, statements regarding Arista's addressable market, products and services, innovation and leadership in data-driven networking. Forward-looking stat ...

Company Overview November 4, 2025 1 Disclaimers This presentation contains forward-looking statements. All statements contained in this presentation other than statements of historical facts, including, without limitation, statements regarding our market opportunity, demand for our product and service offerings, expectations regarding our annualized recurring revenue (ARR), free cash flow, and our other non-GAAP measures, our business strategy, plans and objectives for future operations and expectations reg ...

Stoke Therapeutics Third Quarter 2025 Business Update Webcast for Investors & Analysts November 4, 2025 © COPYRIGHT 2025 | STOKE THERAPEUTICS | 1 Forward-Looking Statements and Other Legal Notices This presentation has been prepared by Stoke Therapeutics, Inc. ("Stoke" or "us") for informational purposes only and not for any other purpose. Nothing contained in this presentation is, or should be construed as, a recommendation, promise or representation by the presenter(s) or Stoke or any officer, director, e ...

Tempus AI, Inc. Investor Presentation Q3 2025 November 4, 2025 Disclaimer This presentation contains forward-looking statements that reflect Tempus AI, Inc.'s (the "Company" or "Tempus") current expectations and projections with respect to, among other things, its financial condition, results of operations, plans, objectives, future performance and business. Forward-looking statements include all statements that are not historical facts. Such forward-looking statements are subject to various risks and uncer ...

3Q Earnings Presentation November 2025 Copyright © 2025 agilon health. Confidential internal document containing proprietary information. Do not distribute. Disclaimers and Forward-Looking Statements FORWARD-LOOKING STATEMENTS AND OTHER INFORMATION Statements in this presentation that are not historical factual statements are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-lo ...

业绩总结 - 公有云年经常性收入（Public Cloud ARR）为6.33亿美元，同比增长11%，占总年经常性收入（Total ARR）的42%[13] - 总年经常性收入（Total ARR）为14.90亿美元，同比增长1%[13] - 最近12个月的GAAP稀释每股收益（EPS）为1.22美元，非GAAP稀释每股收益为2.38美元[9] - 本季度总收入为4.16亿美元，同比下降5%[13] - 经常性收入占总收入的88%[21] - 本季度非GAAP稀释每股收益为0.72美元，较去年同期的0.69美元有所增长[13] - 本季度运营收入占收入的比例为22%[30] 现金流与财务状况 - 运营现金流为3.01亿美元，自由现金流为2.82亿美元[9] - 本季度运营现金流较去年同期增长22%[13] - 本季度自由现金流较去年同期增长27%[13] - Q3'25的自由现金流（FCF）为3,000万美元，年初至今（YTD）自由现金流回报率为76%[35] - Q3'25的现金及现金等价物为4.06亿美元，总债务为4.62亿美元，净现金（债务）为1.59亿美元[39] 未来展望 - 2025财年的总收入预计同比下降5%至7%[43] - 2025财年公共云年经常性收入（ARR）预计增长14%至18%[43] - Q4'25的非GAAP稀释EPS预计在0.53美元至0.57美元之间[48] - 2025财年非GAAP税率预计为23.1%[49] 股票回购与特别项目 - Q3'25的股票回购约为1.4百万股，总回购金额为3,000万美元[34] - 2025年截至9月30日的九个月中，特别项目包括2200万美元（税后1000万美元）用于重组、转型及其他活动[84] - 2024年截至9月30日的九个月中，特别项目包括200万美元（税后200万美元）用于蓝筹交换的销售损失，以及2200万美元（税后1600万美元）用于重组、转型及其他活动[84] 自由现金流定义与说明 - 公司认为自由现金流是对投资者有用的非GAAP指标，自由现金流的定义可能与其他公司的定义不同[104] - 自由现金流被定义为经营活动产生的现金减去与资本支出相关的投资活动[104] - 自由现金流指示在资本支出后生成的现金量，可用于投资、战略收购、加强资产负债表、回购公司股票和偿还债务[107] - 自由现金流不应被视为可自由支配支出的剩余现金流，因为可能存在其他未从该指标中扣除的非自由支配支出[107]

In addition, statements that "we believe" and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as of the date of this presentation, and although we believe such information forms a reasonable basis for su ch statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted a thorough inquiry into, or review of, all potentially available relevant informatio ...